SCHEMBL739900

SCHEMBL739900

Cn1nccc1C(=O)Nc1n[nH]c2sc(C(=O)NC(C)(C)c3ccccc3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.47
ABL1 P00519 2/20 0.46
BCR P11274 2/20 0.46
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NAMPT P43490 1/20 0.37
RAB9A P51151 5/20 0.37
NPC1 O15118 4/20 0.37
PKM P14618 1/20 0.37
PHGDH O43175 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
AHR P35869 1/20 0.35
TACR3 P29371 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1781218 0.94 AURKA (0.43) AURKAABL1BCRALDH1A1SMN1; SMN2
SCHEMBL739086 0.86 AURKA (0.50) AURKAABL1BCRALDH1A1SMN1; SMN2
SCHEMBL740292 0.85 AURKA (0.55) AURKAABL1BCRALDH1A1RAB9A
SCHEMBL4632563 0.84 RAB9A (0.43) ALDH1A1SMN1; SMN2NAMPTRAB9ANPC1
SCHEMBL742071 0.83 AURKA (0.46) AURKAABL1BCRALDH1A1SMN1; SMN2
SCHEMBL740809 0.83 AURKA (0.52) AURKAABL1BCR
SCHEMBL742901 0.82 ABL1 (0.49) AURKAABL1BCRSMN1; SMN2RAB9A
SCHEMBL742025 0.82 AURKA (0.53) AURKAABL1BCRPHGDHTACR3
SCHEMBL743086 0.81 AURKA (0.45) AURKAABL1BCRSMN1; SMN2RAB9A
SCHEMBL743308 0.81 AURKA (0.48) AURKAABL1BCRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed